BUSCADOR RECOLECTA

15 pages, 3 figures.-- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution, Ivermectin (IVM), an antiparasitic drug, has a positive effect against Anisakis simplex s.s. infection and has been used for the treatment and prevention of anisakiasis in humans. However, the molecular mechanism of action of IVM on A. simplex s.s. remains unknown. Herein, tandem mass tag (TMT) labeling and extensive liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) analysis were used to identify the effect of IVM on the proteome of A. simplex s.s. in vitro. During the study, 3433 proteins, of which 1247 had at least two protein unique peptides, were identified. Comparative proteomics analysis revealed that 59 proteins were differentially regulated (DRPs) in IVM-treated larvae, of which 14 proteins were upregulated and 38 were downregulated after 12 h of culture, but after 24 h, 12 proteins were upregulated and 22 were downregulated. The transcription level of five randomly selected DRPs was determined by real-time PCR as a supplement to the proteomic data. The functional enrichment analysis showed that most of the DRPs were involved in oxidoreductase activity, immunogenicity, protein degradation, and other biological processes. This study has, for the first time, provided comprehensive proteomics data on A. simplex s.s. response to IVM and might deliver new insight into the molecular mechanism by which IVM acts on invasive larvae of A. simplex s.s., This work was funded by the GAIN-Xunta de Galicia, project number IN607D 2017/01. Mónica Carrera is supported by the Ramón y Cajal contract (Ministry of Science and Innovation of Spain)., Peer reviewed

Póster.-- 15th International Congress of Parasitology (ICOPA 2022), August 21-26, Copenhagen, Ivermectin (IVM) - an antiparasitic agent - has a beneficial effect on Anisakis simplex s. s. infection and is used for the treatment and prevention of anisakiasis in humans. However, the molecular mechanism of the action of IVM on A. simplex s. s. remains unknown, This work was funded by the GAIN-Xunta de Galicia, project number IN607D 2017/01. M. C. was supported by the Ramón y Cajal contract (Ministry of Science and Innovation of Spain), No